Construct and discriminant validity testing of the FACE-Q Head and Neck Cancer Module for assessing speech and swallowing outcomes for patients undergoing maxillectomy or mandibulectomy

Background: The FACE-Q H&N is a patient reported outcome measure covering multiple constructs for patients with head and neck tumors. Additional testing is needed to determine suitability in assessing speech- and swallowing-related quality of life and function.Methods: FACE-Q H&N, The M. D. Anderson Dysphagia Inventory (MDADI), and Speech Handicap Index (SHI) scores were collected from two patient cohorts who had undergone jaw reconstruction. Construct validity was assessed using convergent validity testing and known groups testing to assess discriminant validity.Results: A priori hypotheses testing demonstrated strong correlations (? > 0.6, p < 0.05) between FACE-Q H&N eating and drinking, swallowing and eating distress scales with MDADI subscales, and between FACE-Q H&N speech function and distress scales and the SHI. Known groups testing demonstrated all instruments could delineate outcomes among patients who had radiation, advanced tumors, and tracheostomy.Conclusion: The FACE-Q H&N may be an alternative for the SHI and MDADI in this patient cohort.

Automated summary

This study evaluated the use of FACE-Q H&N questionnaire, MDADI, and SHI scores for assessing speech and swallowing-related quality of life and function in patients who had undergone jaw reconstruction. The results showed that the FACE-Q H&N questionnaire can be a suitable alternative to the SHI and MDADI in this patient cohort.